DAWN – Day One Biopharmaceuticals, Inc.

DAWN — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

10.67

Margin Of Safety %

Put/Call OI Ratio

1.22

EPS Next Q Diff

0.05

EPS Last/This Y

0.28

EPS This/Next Y

0.71

Price

21.47

Target Price

21.5

Analyst Recom

Performance Q

150.99

Upside

-269.6%

Beta

-1.75

Ticker: DAWN

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	DAWN	21.34	1.01	1.68	55542
2026-03-10	DAWN	21.28	1.02	0.57	57064
2026-03-11	DAWN	21.26	1.02	0.95	57322
2026-03-12	DAWN	21.29	1.22	3.22	53637
2026-03-13	DAWN	21.27	1.22	3.17	53637
2026-03-17	DAWN	21.29	1.25	0.07	54343
2026-03-18	DAWN	21.29	1.26	0.35	54258
2026-03-19	DAWN	21.39	1.25	1.85	54497
2026-03-20	DAWN	21.42	1.25	0.06	55064
2026-03-23	DAWN	21.36	1.10	0.11	45436
2026-03-24	DAWN	21.38	1.09	0.00	45568
2026-03-25	DAWN	21.37	1.08	1.89	45704
2026-03-26	DAWN	21.42	1.08	14.91	45734
2026-03-27	DAWN	21.42	1.25	2.78	49979
2026-03-30	DAWN	21.42	1.25	0.12	49976
2026-03-31	DAWN	21.44	1.23	1.25	50239
2026-04-01	DAWN	21.42	1.23	0.04	50253
2026-04-02	DAWN	21.46	1.22	1.13	50375
2026-04-06	DAWN	21.45	1.22	0.04	50398
2026-04-07	DAWN	21.47	1.22	0.16	50433
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	DAWN	21.35	57.1	-	-0.69
2026-03-10	DAWN	21.28	57.1	-	-0.69
2026-03-11	DAWN	21.26	57.1	-	-0.69
2026-03-12	DAWN	21.29	57.1	-	-0.69
2026-03-13	DAWN	21.32	57.1	-	-0.72
2026-03-17	DAWN	21.29	57.1	-	-0.72
2026-03-18	DAWN	21.30	57.1	-	-0.72
2026-03-19	DAWN	21.39	57.1	-	-0.72
2026-03-20	DAWN	21.44	57.1	-	-0.72
2026-03-23	DAWN	21.36	57.1	-	-0.72
2026-03-24	DAWN	21.38	50.9	-	-0.76
2026-03-25	DAWN	21.37	50.9	-	-0.76
2026-03-26	DAWN	21.41	50.9	-	-0.76
2026-03-27	DAWN	21.42	50.9	-	-0.76
2026-03-30	DAWN	21.42	50.9	-	-0.76
2026-03-31	DAWN	21.44	50.9	-	-0.76
2026-04-01	DAWN	21.42	50.9	-	-0.76
2026-04-02	DAWN	21.46	50.9	-	-0.76
2026-04-06	DAWN	21.46	50.9	-	-0.76
2026-04-07	DAWN	21.47	50.9	-	-0.76
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	DAWN	-0.23	-6.62	13.25
2026-03-10	DAWN	-0.23	-6.62	13.25
2026-03-11	DAWN	-0.23	-6.62	13.08
2026-03-12	DAWN	-0.23	-6.62	13.08
2026-03-13	DAWN	-0.23	-6.62	13.39
2026-03-17	DAWN	-0.23	-6.66	13.39
2026-03-18	DAWN	-0.23	-6.66	13.39
2026-03-19	DAWN	-0.23	-6.66	13.39
2026-03-20	DAWN	-0.23	-6.66	13.39
2026-03-23	DAWN	-0.23	-6.66	13.39
2026-03-24	DAWN	-0.23	-6.66	13.39
2026-03-25	DAWN	-0.23	-6.66	10.67
2026-03-26	DAWN	-0.23	-6.66	10.67
2026-03-27	DAWN	-0.23	-6.66	10.67
2026-03-30	DAWN	-0.23	-6.73	10.67
2026-03-31	DAWN	-0.23	-6.73	10.67
2026-04-01	DAWN	-0.23	-6.73	10.67
2026-04-02	DAWN	-0.23	-6.73	10.67
2026-04-06	DAWN	-0.23	-6.74	10.67
2026-04-07	DAWN	-0.23	-6.74	10.67
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.17

Avg. EPS Est. Next Quarter

-0.16

Insider Transactions

-0.23

Institutional Transactions

-6.74

Beta

-1.75

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

25.2

Max Drawdown 5-Year %

Target Price

21.5

P/E

Forward P/E

PEG

P/S

14.01

P/B

5.01

P/Free Cash Flow

EPS

-1.04

Average EPS Est. Cur. Y

-0.76

EPS Next Y. (Est.)

-0.04

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-67.85

Relative Volume

0.41

Return on Equity vs Sector %

-51.8

Return on Equity vs Industry %

-35.2

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.17

EBIT Estimation

◆ DAWN Healthcare

$21.46

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

8/25

Volume

11/15

Valuation

3/20

TP/AR

0/10

Options

4/10

RSI

81.4

Range 1M

87.5%

Sup Dist

0.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

19/30

Estimates

1/20

Inst/Vol

4/15

Options

4/10

EPS Yr

25%

EPS NY

76.3%

52W%

99.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +0.2% upside

Quality

6/30

Valuation

2/30

Growth

16/25

Stability

7/10

LT Trend

1/5

Upside

+0.2%

Quality

Day One Biopharmaceuticals, Inc

Sector: Healthcare

Industry: Biotechnology

Employees: 178

Day One Biopharmaceuticals, Inc., a commercial-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral and brain-penetrant type II rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It is also developing DAY301, a PTK7 targeted ADC composed of a novel humanized anti-PTK7 immunoglobulin G1 monoclonal antibody conjugated with a topoisomerase I inhibitor via a highly stable and hydrophilic modified valine-alanine (VA) cleavable linker for the treatment of patients with advanced solid tumors; and Emi-Le, an antibody-drug conjugate that targets B7- H4 conjugated to an auristatin anti-tubulin payload as a component of a proprietary linker-payload platform developed by Mersana Therapeutics that is in Phase 1 clinicla trial for the treatment of breast cancer, ovarian cancer, endometrial cancer, and adenoid cystic carcinoma (ACC). Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.

DAWN

Latest News

—

Caricamento notizie per DAWN…

stock quote shares DAWN – Day One Biopharmaceuticals, Inc. Stock Price stock today

news today DAWN – Day One Biopharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DAWN – Day One Biopharmaceuticals, Inc. yahoo finance google finance

stock history DAWN – Day One Biopharmaceuticals, Inc. invest stock market

stock prices DAWN premarket after hours

ticker DAWN fair value insiders trading

DAWN – Day One Biopharmaceuticals, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: DAWN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y